Improving balance and gait in stroke patients using lumbar mobilization techniques

Effects of Mulligan-Based Lumbar Mobilization on Trunk Position Sense, Balance, and Gait in Stroke Survivors: A Randomized Study

Not applicable Interventional Gulhane School of Medicine · NCT06887114

This study tests if a new way of moving the lower back, combined with regular therapy, can help people who had a stroke improve their balance and walking.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment40 (estimated)
Ages30 Years to 65 Years
SexAll
SponsorGulhane School of Medicine Academic / other
Locations1 site (Ankara)
Trial IDNCT06887114 on ClinicalTrials.gov

What this trial studies

This study investigates the effectiveness of Mulligan mobilization combined with conventional therapy to enhance gait, balance, and trunk position sense in stroke patients. Stroke often leads to significant balance impairments, increasing the risk of falls and reducing independence in daily activities. The research focuses on individuals who have experienced their first stroke and have been diagnosed within a specific timeframe. By targeting lumbar mobility and trunk stability, the study aims to improve rehabilitation outcomes for these patients.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 30 to 65 who have experienced their first stroke between 6 to 24 months prior and have a Modified Rankin Scale score of 3 or less.

Not a fit: Patients with a history of musculoskeletal disorders affecting the spine or other neurological conditions may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly enhance balance and mobility in stroke patients, leading to improved independence and quality of life.

How similar studies have performed: While the Mulligan Concept has been effective in treating musculoskeletal disorders, its application in stroke rehabilitation is relatively novel and has limited prior research.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must meet all of the following conditions to be eligible for the study:

  * Diagnosed with stroke by a neurologist.
  * Aged 30 to 65 years.
  * First-ever stroke (single episode).
  * Stroke duration between 6 to 24 months.
  * Score of ≤3 on the Modified Rankin Scale (mRS).
  * Score of ≥24 on the Mini-Mental State Examination (MMSE).

Exclusion Criteria:

* Participants will be excluded if they meet any of the following conditions:

  * History of musculoskeletal disorders affecting the spine (e.g., cancer, scoliosis, spondylolisthesis, rheumatoid arthritis, ankylosing spondylitis).
  * Previous lumbar spine surgery.
  * Presence of neurological conditions other than stroke (e.g., Parkinson's disease, multiple sclerosis).
  * Severe visual impairment affecting balance or walking.

Where this trial is running

Ankara

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Balance Impairments in Stroke PatientsStroke, Lumbar Mobilization, Mulligan, Balance, Trunk Position Sense and Gait.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.